African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2285

Full Length Research Paper

The effect of vanadium on rat hypercholesterolemia in the presence and absence of statins

Nasr L. R.
  • Nasr L. R.
  • Clincal Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, Kingdom of Saudi Arabia.
  • Search for this author on:
  • Google Scholar
Saber M. E.
  • Saber M. E.
  • Clincal Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, Kingdom of Saudi Arabia.
  • Search for this author on:
  • Google Scholar
Hussam B.
  • Hussam B.
  • iochemistry and molecular medicine department, college of medicine, Taibah University, Madinah, Kingdom of Saudi Arabia.
  • Search for this author on:
  • Google Scholar
Salma A. R.
  • Salma A. R.
  • Depaetment of Pathology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Search for this author on:
  • Google Scholar
Muzaffar I.
  • Muzaffar I.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh Kingdom of Saudi Arabia.
  • Search for this author on:
  • Google Scholar


  •  Received: 26 August 2017
  •  Accepted: 03 October 2017
  •  Published: 22 October 2017

Abstract

Vanadium may or may not be a cholesterol-lowering agent. It could potentially be used as an additional therapy or alone in therapies for treatment of dyslipidemia. This study aimed to investigate the effect of vanadium on hypercholesterolemia in the presence and absence of statins. Sixty rats were divided into five groups. The first group was kept on a normal diet and the second group was kept on a high fat diet. The three remaining groups of rats were prepared for the treatment; one group received simvastatin, one was given vanadium, and the third group was tested with both. Blood samples from all groups were investigated. Body functions were considered a tool in expressing efficacy and toxicity for the three types of treatment and were compared with the control groups. Vanadium alone causes marked increases in cholesterol levels. When added to statins, all lipid values were negatively affected as compared to the statins-only treated group. Rats with high fat diets showed significant (P≤ 0.05) elevation in the levels of serum triglycerides (TG), total cholesterol (TC), low density lipoprotein concentration (LDL-C) and very low density lipoprotein concentration (VLDL-C) as compared to the control group. All generated data proved that vanadium is impracticable for treating dyslipidemia. Vanadium is not safe or efficient in therapies for lowering cholesterol and other lipid levels.

 

Key words: Vanadium, statin, body functions, cholesterol, toxicity, rats.

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 11 No. 39
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES